Featurestory from our newsletter

December 17. 2019 Analytical Trends

Stability Testing and Forced Degradation Stress Tests - Proactive Risk Management

Whereas the durability of many consumables, have a strong tendency to decrease, stability is and remains a crucial factor for pharmaceuticals. That is…

July 04. 2019 Analytical Trends

Accelerating Research and Development: the Multi-Attribute Method (MAM)

Fast, Thorough, and Efficient : The Multi-Attribute Method (MAM)

March 08. 2019 Analytical Trends

High Throughput Analytics Herald a Paradigm Shift in the Development of Biopharmaceuticals

Biopharmaceuticals have revolutionized therapies of various diseases. In particular with regard to chronical and/or severe clinical conditions like…

February 08. 2019 Analytical Trends

Biosimilar Drug Development – the analytical strategy is a keyfactor for your success

Biosimilar Drug Development – the analytical strategy is a keyfactor for your success

The generation of analytical data for the comparison between…

February 05. 2019 Analytical Trends

Outsourcing as a Key Strategy to Lower Your Costs and to Accelerate Your Product’s Launch

Outsourcing as a Key Strategy to Lower Your Costs and to Accelerate Your Product’s Launch

What makes a good partnership? Passion? Common goals?…

February 01. 2019 Analytical Trends

Mass Spectrometry for Early and Enclosing Host Cell Protein Identification

Powered by Protagen Protein Services: Mass Spectrometry for Early and Enclosing Host Cell Protein Identification

Mass spectrometry (MS) becomes an…

See here our latest newsletter. The company is constantly informing in E-Mail about latest technology developments,
typical applications, as well as strategic approaches in biotherapeutic development.

NEWS & EVENTS

See here our latest news and the next events where we are participating

Whereas the durability of many consumables, have a strong tendency to decrease, stability is and remains a crucial factor for pharmaceuticals. That is…

Fast, Thorough, and Efficient : The Multi-Attribute Method (MAM)

Heilbronn, Germany and Boston, MA – April 10th, 2019 – Protagen Protein Services GmbH (PPS), a full-service contract research organization (CRO) in…

FDA Withdraws Draft Guidance on Biosimilar Development

The U.S. Food and Drug Administration (FDA) withdrew its draft guidance on statistical…

Monograph for Etanercept is published

The monograph for Etanercept (2895) is published in the Supplement 9.5 of the European…

CMC Analytical Comparability: Methods & Strategies for Biologics, Biosimilars

Protagen Protein Services is pleased to invite you to our co-organized event in…

FDA Withdraws Draft Guidance on Biosimilar Development

Featurestory from our newsletter

Stability Testing and Forced Degradation Stress Tests - Proactive Risk Management

Accelerating Research and Development: the Multi-Attribute Method (MAM)

High Throughput Analytics Herald a Paradigm Shift in the Development of Biopharmaceuticals

Biosimilar Drug Development – the analytical strategy is a keyfactor for your success

Outsourcing as a Key Strategy to Lower Your Costs and to Accelerate Your Product’s Launch

Mass Spectrometry for Early and Enclosing Host Cell Protein Identification

Newsletter

NEWS & EVENTS

Stability Testing and Forced Degradation Stress Tests - Proactive Risk Management

Accelerating Research and Development: the Multi-Attribute Method (MAM)

Protagen Protein Services and BioAnalytix Merge to Create Global Analytic Service Partner for Biopharmaceuticals

Monograph for Etanercept is published

CMC Analytical Comparability: Methods & Strategies for Biologics, Biosimilars